Cardinal Health, Inc. $CAH Shares Purchased by Banco Santander S.A.

Banco Santander S.A. grew its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 12.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 117,354 shares of the company’s stock after purchasing an additional 13,228 shares during the quarter. Banco Santander S.A.’s holdings in Cardinal Health were worth $18,420,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Strategy Asset Managers LLC purchased a new stake in Cardinal Health in the 3rd quarter valued at $775,000. Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Cardinal Health by 15.3% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 37,833 shares of the company’s stock valued at $5,938,000 after acquiring an additional 5,030 shares during the last quarter. Versor Investments LP acquired a new position in shares of Cardinal Health during the 3rd quarter valued at about $2,090,000. Atle Fund Management AB grew its holdings in shares of Cardinal Health by 13.1% in the third quarter. Atle Fund Management AB now owns 30,297 shares of the company’s stock valued at $4,755,000 after purchasing an additional 3,500 shares during the period. Finally, Machina Capital S.A.S. increased its position in Cardinal Health by 248.0% during the third quarter. Machina Capital S.A.S. now owns 27,054 shares of the company’s stock worth $4,246,000 after purchasing an additional 19,280 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Trading Up 0.4%

Shares of NYSE CAH opened at $227.10 on Friday. The stock has a market capitalization of $53.44 billion, a PE ratio of 32.68, a PEG ratio of 1.46 and a beta of 0.64. Cardinal Health, Inc. has a twelve month low of $120.72 and a twelve month high of $230.81. The stock has a fifty day simple moving average of $213.56 and a 200-day simple moving average of $186.44.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, February 5th. The company reported $2.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.31 by $0.32. The firm had revenue of $65.63 billion for the quarter, compared to analyst estimates of $64.88 billion. Cardinal Health had a negative return on equity of 92.50% and a net margin of 0.68%.Cardinal Health’s revenue was up 18.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.93 EPS. On average, equities analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st will be issued a $0.5107 dividend. The ex-dividend date is Wednesday, April 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s payout ratio is 29.35%.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on CAH shares. Deutsche Bank Aktiengesellschaft increased their price target on shares of Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a research note on Tuesday, November 18th. Zacks Research upgraded Cardinal Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 12th. Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 21st. Evercore upped their price target on Cardinal Health from $250.00 to $260.00 in a research note on Friday, February 6th. Finally, Mizuho increased their price target on Cardinal Health from $222.00 to $235.00 and gave the stock an “outperform” rating in a report on Friday, February 6th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $245.20.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.